...
首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >Noncompetitive Metabotropic Glutamate_5 Receptor Antagonist (E)-2-Methyl-6-styryl-pyridine (SIB1893) Depresses Glutamate Release through Inhibition of Voltage-Dependent Ca~(2+) Entry in Rat Cerebrocortical Nerve Terminals (Synaptosomes)
【24h】

Noncompetitive Metabotropic Glutamate_5 Receptor Antagonist (E)-2-Methyl-6-styryl-pyridine (SIB1893) Depresses Glutamate Release through Inhibition of Voltage-Dependent Ca~(2+) Entry in Rat Cerebrocortical Nerve Terminals (Synaptosomes)

机译:非竞争性代谢型谷氨酸5受体拮抗剂(E)-2-甲基-6-苯乙烯基吡啶(SIB1893)通过抑制大鼠脑皮质神经末梢(突触小体)的电压依赖性Ca〜(2+)进入来抑制谷氨酸释放。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The effect of (E)-2-methyl-6-styryl-pyridine (SIB1893),a selective metabotropic glutamate (subtype 5) receptor (mGlu_5R) antagonist,on glutamate release from isolated nerve terminals (synaptosomes) was examined.SIB1893 caused a potent inhibition of the Ca~(2+)-dependent release of glutamate evoked by 4-aminopyridine (4AP).That the implied mGlu_5R-mediated modulation was contingent on diacylglycerol stimulation of protein kinase C (PKC) was indicated by PKC activator phorbol dibutyrate and PKC inhibitor Ro 32-0432 (bisindolylmaleimide XI),respectively,superceding or suppressing the inhibitory effect of SIB1893.The inhibitory action of SIB1893 was not due to it decreasing synaptosomal excitability or directly interfering with the release process at some point subsequent to Ca~(2+) influx,because SIB1893 did not alter the 4AP-evoked depolarization of the synaptosomal plasma membrane potential orCa~(2+) ionophore ionomycin-induced glutamate release.Rather,examination of the effect of SIB1893 on cytosolic [Ca~(2+)] revealed that the diminution of glutamate release could be attributed to a reduction in voltage-dependent Ca~(2+) influx.Consistent with this,the SIB1893-mediated inhibition of glutamate release was completely prevented in synaptosomes pretreated with a combination of the N-and P/Q-type Ca~(2+) channel block-ers,omega-conotoxin GVIA,and omega-agatoxin IVA.Together,these results suggest that noncompetitive antagonism of mGlu_5Rs using SIB1893 effects a decrease in PKC activation,which subsequently attenuates the Ca~(2+) entry through voltage-dependent N- and P/Q-type Ca~(2+) channels to cause a decrease in evoked glutamate release.These actions of SIB1893 and related agents may contribute to their neuroprotective effects in excitotoxic injury.
机译:研究了选择性代谢型谷氨酸(5型)受体(mGlu_5R)拮抗剂(E)-2-甲基-6-苯乙烯基吡啶(SIB1893)对离体神经末梢(突触体)释放谷氨酸的影响。强烈抑制4-氨基吡啶(4AP)诱发的谷氨酸Ca〜(2+)依赖性释放和PKC抑制剂Ro 32-0432(双吲哚基马来酰亚胺XI)分别取代或抑制SIB1893的抑制作用。 (2+)流入,因为SIB1893并未改变4AP诱发的突触质膜电位或Ca〜(2+)离子载体离子霉素诱导的谷氨酸释放。相反,检查了SIB18的作用胞质[Ca〜(2+)]的93揭示了谷氨酸释放的减少可能归因于电压依赖性Ca〜(2+)流入的减少。与此相一致,SIB1893介导的谷氨酸释放的抑制作用是完全的。 N和P / Q型Ca〜(2+)通道阻滞剂,ω-芋螺毒素GVIA和ω-藻毒素IVA联合预处理可预防突触小体。这些结果表明,使用mGlu_5Rs的非竞争性拮抗作用SIB1893降低了PKC激活,随后通过电压依赖性N和P / Q型Ca〜(2+)通道减弱了Ca〜(2+)的进入,从而引起了诱发的谷氨酸释放的减少。 SIB1893和相关药物可能对兴奋性毒性损伤的神经保护作用有所贡献。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号